Outcome of 12-weeks Triple Therapy (TT), including Sofosbuvir (SOF), Ribavirin and Pegylated interferon-Alfa in all non-cirrhotic patients with chronic Hepatitis-C Genotype-3 infection. mfm [Internet]. 2024 May 19 [cited 2025 Nov. 16];28(7). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/4148